We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Radial Scars Following Breast Biopsy Advocate Surgical Excision

By HospiMedica International staff writers
Posted on 05 Apr 2010
Radial scars encountered after breast biopsy should prompt surgical excision to exclude possible malignancy, according to a new study.

Researchers at the University of Udine (Italy) conducted a retrospective record review of 4,458 consecutive imaging-guided breast biopsies. More...
The mammographic images, sonographic images, and surgical findings were reviewed in 62 cases in which surgical excision results were available of the radial scars found during the guided biopsy. The underestimation rate of the malignancy of percutaneous biopsy was calculated, and differences in sonographic and mammographic appearances between the radial scars (with and without associated malignancy) were then evaluated.

The results showed that the percutaneous malignancy underestimation rate was 8% overall, with 9% for sonography guided 14-gauge biopsies, and 5% for stereotactically guided 11-gauge vacuum-assisted biopsies. Mammographic and sonographic appearances were not significantly different between radial scars, with or without associated malignancy. The researchers thus concluded that a diagnosis of a radial scar based on percutaneous biopsy results or mammographic and sonographic appearances of a lesion diagnosed as a radial scar could not exclude an associated malignancy at subsequent surgical excision. The results of the study were published in the April 2010 issue of the American Journal of Roentgenology (AJR).

"Radial scars are complex breast lesions that are classified as benign; however, up to 40% of them are associated with an underlying malignancy,” said lead author Anna Linda, M.D., of the institute of radiology. "Our results suggest that surgical excision is required for lesions yielding radial scars at percutaneous biopsy regardless of their mammographic and sonographic appearance.”

Radial scar, also known as sclerosing complex lesion, represents a possible premalignant lesion generally 10 mm or less in diameter, consisting of a central fibroelastotic zone from which tubular structure radiate; it may be two layered or exhibit intraluminal proliferation. It is also a radiological entity, detected via mammography by typical but not specific signs: the presence of the central radiolucency; the presence of radial long thin spicules; varying appearance in different projections; radiolucent linear structures parallel to spicules; and absence of palpable lesion or skin changes.

Related Links:

University of Udine



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Cardiograph Device
PageWriter TC35
PACS Workstation
PaxeraView PRO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.